Dose optimisation in oncology: Insights from AACR 2026 and i...
Five years after its launch, the FDA’s Project Optimus remained a key theme in discussions at AACR 2026.
Newsletters and Deep Dive digital magazine
Five years after its launch, the FDA’s Project Optimus remained a key theme in discussions at AACR 2026.
Longevity has been discussed for a while now in the context of life sciences and pharma - we take a look at what's new now with Anat Naschitz.
Healthcare organisations aren’t struggling because they lack growth strategies, they’re struggling because they can’t operationalise them.
Following Asembia 2026, pharmaphorum spoke with Krista Pinto, a leading commercialisation expert at EVERSANA.
The Pharma Specialized Network (PSN) provides a globally integrated solution for delivering end-to-end distribution to clinical sites, laboratories, hospitals, and patients.
Editor's Picks
Newsletters and Deep Dive
digital magazine